Review of Allopregnanolone Agonist Therapy for the Treatment of Depressive Disorders

Review of Allopregnanolone Agonist Therapy for the Treatment of Depressive Disorders

Autumn Walkery,1 Lauren D Leader,1 Emily Cooke,2 Amy VandenBerg1 1Department of Pharmacy Services, Michigan Medicine, Ann Arbor, MI, USA; 2Department of Pharmacy, Barnes-Jewish Hospital, St. Louis, MO, USACorrespondence: Lauren D LeaderMichigan Medicine, Department of Pharmacy Services, 1540 E. Medi...

Full description

Bibliographic Details
Main Authors:	Walkery A, Leader LD, Cooke E, VandenBerg A
Format:	Article
Language:	English
Published:	Dove Medical Press 2021-07-01
Series:	Drug Design, Development and Therapy
Subjects:	postpartum bipolar brexanolone zuranolone
Online Access:	https://www.dovepress.com/review-of-allopregnanolone-agonist-therapy-for-the-treatment-of-depres-peer-reviewed-fulltext-article-DDDT

Similar Items

Allopregnanolone in postpartum depression: Role in pathophysiology and treatment
by: Samantha Meltzer-Brody, et al.
Published: (2020-05-01)

Pharmacological Treatment Strategies for Postpartum Depression
by: O. Vasiliu
Published: (2022-06-01)

Efficacy and safety of zuranolone in major depressive disorder: a meta-analysis of factor effect and dose-response analysesResearch in context
by: Yu-Wei Lin, et al.
Published: (2023-12-01)

Clinical Efficacy of a 2-Week Treatment Course of Zuranolone for the Treatment of Major Depressive Disorder and Postpartum Depression: Outcomes From the Clinical Development Program
by: A. Clayton, et al.
Published: (2022-06-01)

The Role of HPA Axis and Allopregnanolone on the Neurobiology of Major Depressive Disorders and PTSD
by: Felipe Borges Almeida, et al.
Published: (2021-05-01)

Brexanolone, a GABAA Modulator, in the Treatment of Postpartum Depression in Adults: A Comprehensive Review
by: Amber N. Edinoff, et al.
Published: (2021-09-01)

Allopregnanolone in Postpartum Depression
by: Graziano Pinna, et al.
Published: (2022-04-01)

Treating Postpartum Depression: What Do We Know about Brexanolone?
by: Muneeza Ali, et al.
Published: (2021-07-01)

Efficacy and tolerability of zuranolone in patients with depression: a meta-analysis of randomized controlled trials
by: Youjia Qiu, et al.
Published: (2024-01-01)

Corrigendum: Allopregnanolone, the Neuromodulator Turned Therapeutic Agent: Thank You, Next?
by: Graziano Pinna
Published: (2020-07-01)

Patient-reported perceptions of brexanolone in the treatment of postpartum depression: A qualitative analysis
by: Aaron Salwan, PharmD, MPH, BCPP, et al.
Published: (2023-01-01)

PPAR and functional foods: Rationale for natural neurosteroid-based interventions for postpartum depression
by: Francesco Matrisciano, et al.
Published: (2020-05-01)

The role of allopregnanolone in depressive-like behaviors: Focus on neurotrophic proteins
by: Felipe Borges Almeida, et al.
Published: (2020-05-01)

Navigating the landscape of Postpartum Depression: a comprehensive review
by: Kinga Panuciak, et al.
Published: (2024-02-01)

Allopregnanolone, the Neuromodulator Turned Therapeutic Agent: Thank You, Next?
by: Graziano Pinna
Published: (2020-05-01)

Investigational Drugs for the Treatment of Depression (Part 2): Glutamatergic, Cholinergic, Sestrin Modulators, and Other Agents
by: Octavian Vasiliu
Published: (2022-06-01)

Efficacy and safety of zuranolone in the treatment of major depressive disorder: a meta-analysis
by: Shuyu Wang, et al.
Published: (2024-01-01)

Zuranolone – synthetic neurosteroid in treatment of mental disorders: narrative review
by: Rafał Marecki, et al.
Published: (2023-12-01)

The Neuroactive Steroid Pregnanolone Glutamate: Anticonvulsant Effect, Metabolites and Its Effect on Neurosteroid Levels in Developing Rat Brains
by: Eva Kudova, et al.
Published: (2021-12-01)

Divergent Transcriptomic Effects of Allopregnanolone in Postpartum Depression
by: Sarah A. Rudzinskas, et al.
Published: (2023-06-01)

Advances in Screening for Postpartum Hypomanic Symptoms and Their Relationship with Postpartum Depression and Bipolar Disorder
by: Qianqian ZHAO, Yanli ZHOU, Chaoqun XIAO, Wenting LIU, Zhongyi FAN, Yu CHEN
Published: (2022-07-01)

Postpartum Başlangıç Olup Olmamasına Göre Bipolar Bozukluk Tanılı Kadın Hastaların Klinik Parametrelerinin Değerlendirilmesi
by: Bahri İnce, et al.
Published: (2021-09-01)

Investigational Drugs for the Treatment of Depression (Part 1): Monoaminergic, Orexinergic, GABA-Ergic, and Anti-Inflammatory Agents
by: Octavian Vasiliu
Published: (2022-06-01)

Multicentre evaluation of perinatal pharmacological management in women with bipolar disorder
by: M. Casanova Dias, et al.
Published: (2021-04-01)

Postpartum depression: bipolar or unipolar? Analysis of 434 Polish postpartum women
by: Rafał R. Jaeschke, et al.

Postpartum Relapse in Patients with Bipolar Disorder
by: Javier Conejo-Galindo, et al.
Published: (2022-07-01)

Olanzapine and quetiapine in the prevention of a new mood episode in women with bipolar disorder during the postpartum period: a retrospective cohort study
by: Faruk Uguz, et al.

Therapy for depression in bipolar affective disorder
by: N. A. Tyuvina, et al.
Published: (2016-07-01)

Mother-to-Infant Bonding in Women With a Bipolar Spectrum Disorder
by: Myrthe G. B. M. Boekhorst, et al.
Published: (2021-03-01)

“What if I get ill?” Perinatal concerns and preparations in primi- and multiparous women with bipolar disorder
by: Teija M. S. Anke, et al.
Published: (2019-03-01)

Postpartum depression — risk factors, clinical and treatment aspects
by: M. A. Makarova, et al.
Published: (2021-08-01)

An update on recently approved long-acting injectable second-generation antipsychotics: Knowns and unknowns regarding their use
by: Amy M. VandenBerg, PharmD, BCPP
Published: (2022-11-01)

Differences between Depression Episodes of Bipolar Disorder I and II
by: Leman Inanc, et al.
Published: (2013-09-01)

Postpartal depression and thyroid disorders
by: Jandrić-Kočić Marijana C.
Published: (2020-01-01)

Drug Therapy and Postpartum Disorders /
by: Libal, Autumn, author
Published: (c200)

Mothers with and without bipolar disorder and their infants: group differences in mother-infant interaction patterns at three months postpartum
by: Teija M. S. Anke, et al.
Published: (2019-09-01)

Use of Electro-Convulsive Therapy as a Bipolar Disorder Treatment: A Systematic Review
by: E. Miranda Ruiz, et al.
Published: (2022-06-01)

Depression: The Silent Crisis during Pregnancy
by: Jittima Rujiwetpongstorn
Published: (2017-09-01)

Factors Associated with the Prevalence of Postpartum Anxiety Disorder and Depression in Syrian Migrant Women Living in Turkey: A Cross-Sectional Study
by: Muhammed Atak, et al.
Published: (2023-09-01)

Postpartum depression – a mood disorder after delivery
by: Dagna Siedlecka, et al.
Published: (2019-09-01)